Robbie Marcus Analyst PerformanceMedtech Senior Analyst at JPMorgan Chase & Co.Robbie Marcus is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 24 publicly traded companies. Over the past year, Robbie Marcus has issued 30 stock ratings, including buy, hold, and sell recommendations. While full access to Robbie Marcus' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robbie Marcus' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings54 Last 9 YearsBuy Recommendations50.00% 27 Buy RatingsCompanies Covered24 Unique Companies Ratings Distribution54RatingsDistribution of strong buy, buy, hold, and sell ratings by Robbie Marcus.RatingPercentageCount Strong Buy0.0%0 ratings Buy50.0%27 ratings Hold40.7%22 ratings Sell9.3%5 ratingsOut of 54 total stock ratings issued by Robbie Marcus at JPMorgan Chase & Co., the majority (50.0%) have been Buy recommendations, followed by 40.7% Hold and 9.3% Sell.Best & Worst CallsBest Call000.0%INGNJun 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RXSTFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ58.3% of companies on NASDAQ14 companiesNYSE41.7% of companies on NYSE10 companiesRobbie Marcus, an analyst at JPMorgan Chase & Co., currently covers 24 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical24 companies100.0%Robbie Marcus of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED INSTRUMENTS9 companies37.5%MED PRODUCTS8 companies33.3%MED/DENTAL - SUPP3 companies12.5%MEDICAL INFO SYS2 companies8.3%HEALTH INFORMATION SERVICES1 company4.2%MEDICAL SERVICES1 company4.2% Robbie Marcus' Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPODDInsulet5/7/2026Lower Price Target$151.28$275.00Overweight$0.0000.00% ROIINSPInspire Medical Systems5/5/2026Lower Price Target$48.24$54.00Neutral$0.0000.00% ROISYKStryker5/1/2026Lower Price Target$300.10$400.00Overweight$0.0000.00% ROIMMSIMerit Medical Systems5/1/2026Lower Price Target$62.06$77.00Overweight$0.0000.00% ROIGEHCGE HealthCare Technologies4/30/2026Lower Price Target$60.84$65.00Neutral$0.0000.00% ROICNMDCONMED4/30/2026Lower Price Target$36.63$40.00Neutral$0.0000.00% ROIZBHZimmer Biomet4/29/2026Lower Price Target$80.31$95.00Neutral$0.0000.00% ROIHTFLHeartflow3/19/2026Lower Price Target$25.84$35.00Overweight$0.0000.00% ROIPODDInsulet2/19/2026Lower Price Target$245.43$340.00Overweight$0.0000.00% ROIMDTMedtronic2/18/2026Lower Price Target$96.84$100.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BSXBoston Scientific2/5/2026Lower Price Target$78.37$100.00Overweight$0.0000.00% ROIEWEdwards Lifesciences12/18/2025Upgrade$84.85$100.00Overweight$0.0000.00% ROIINSPInspire Medical Systems12/16/2025Boost Price Target$114.07$118.00Neutral$0.0000.00% ROICOOCooper Companies12/5/2025Boost Price Target$83.45$78.00Neutral$0.0000.00% ROIMDTMedtronic11/13/2025Boost Price Target$96.61$100.00Neutral$0.0000.00% ROIHTFLHeartflow11/13/2025Boost Price Target$31.65$40.00Overweight$0.0000.00% ROIZBHZimmer Biomet11/6/2025Reiterated Rating$87.59$100.00Neutral$0.0000.00% ROICNMDCONMED11/6/2025Lower Price Target$44.14$52.00Neutral$0.0000.00% ROIRXSTRxSight11/6/2025Boost Price Target$8.61$9.00Underweight$0.0000.00% ROICBLLCeriBell11/5/2025Lower Price Target$11.78$17.00Overweight$0.0000.00% ROIINSPInspire Medical Systems11/4/2025Lower Price Target$86.27$82.00Neutral$0.0000.00% ROIIARTIntegra LifeSciences10/31/2025Boost Price Target$11.51$13.00Underweight$0.0000.00% ROIEWEdwards Lifesciences10/31/2025Boost Price Target$82.41$90.00Neutral$0.0000.00% ROIDXCMDexCom10/31/2025Lower Price Target$58.90$75.00Neutral$0.0000.00% ROIBLCOBausch + Lomb10/30/2025Boost Price Target$15.20$16.00Neutral$0.0000.00% ROIHTFLHeartflow9/2/2025Initiated Coverage$31.50$36.00Overweight$0.0000.00% ROICOOCooper Companies8/28/2025Lower Price Target$64.44$66.00Neutral$0.0000.00% ROIINSPInspire Medical Systems8/5/2025Downgrade$130.79$110.00Neutral$0.0000.00% ROIEWEdwards Lifesciences7/25/2025Boost Price Target$79.92$85.00Neutral$0.0000.00% ROICOOCooper Companies5/30/2025Reiterated Rating$79.96$76.00Neutral$0.0000.00% ROINPCENeuroPace5/14/2025Boost Price Target$16.08$16.00Overweight$00.0000.00% ROICVRXCVRx5/9/2025Reiterated Rating$7.79$7.00Underweight$0.0000.00% ROIIARTIntegra LifeSciences5/6/2025Lower Price Target$13.27$12.00Underweight$00.0000.00% ROIINSPInspire Medical Systems5/6/2025Lower Price Target$149.88$195.00Overweight$00.0000.00% ROIZBHZimmer Biomet5/6/2025Lower Price Target$90.65$105.00Overweight$00.0000.00% ROICNMDCONMED5/1/2025Lower Price Target$56.06$58.00Neutral$00.0000.00% ROIRXSTRxSight4/4/2025Reiterated Rating$16.21$17.00Underweight$0.0000.00% ROIMMSIMerit Medical Systems3/28/2025Initiated Coverage$103.27$120.00Overweight$00.0000.00% ROICOOCooper Companies3/7/2025Lower Price Target$84.04$110.00Overweight$00.0000.00% ROIRXSTRxSight2/26/2025Lower Price Target$27.57$40.00Overweight$0.0000.00% ROISpaceX will mint billionaires. You won't be one of them. (Ad)By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billion - you'd be buying at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's path, still priced like Wall Street hasn't noticed. It powers the infrastructure Musk's operation can't run without. Dylan Jovine is naming the ticker free - before the June S-1 closes the window.Get the ticker now before the June S-1 closes the windowBAXBaxter International2/21/2025Lower Price Target$33.49$36.00Neutral$00.0000.00% ROICNMDCONMED2/6/2025Downgrade$74.35$70.00Neutral$00.0000.00% ROISYKStryker1/29/2025Boost Price Target$394.92$445.00Overweight$000.0000.00% ROIISRGIntuitive Surgical1/24/2025Boost Price Target$608.66$675.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
